{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:45:49Z","timestamp":1773330349993,"version":"3.50.1"},"reference-count":74,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2018,9,2]]},"DOI":"10.1080\/17425255.2018.1506765","type":"journal-article","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T14:24:36Z","timestamp":1532787876000},"page":"901-910","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir\/sofosbuvir\/ribavirin in the treatment of chronic hepatitis C"],"prefix":"10.1080","volume":"14","author":[{"given":"Antonio","family":"Rivero-Juarez","sequence":"first","affiliation":[{"name":"Unidad de Enfermedades Infecciosas, Instituto Maimonides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba (IMIBIC), Hospital Universitario Reina Sof\u00eda de C\u00f3rdoba, Universidad de C\u00f3rdoba, Cordoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Brieva","sequence":"additional","affiliation":[{"name":"Unidad de Enfermedades Infecciosas, Instituto Maimonides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba (IMIBIC), Hospital Universitario Reina Sof\u00eda de C\u00f3rdoba, Universidad de C\u00f3rdoba, Cordoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Frias","sequence":"additional","affiliation":[{"name":"Unidad de Enfermedades Infecciosas, Instituto Maimonides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba (IMIBIC), Hospital Universitario Reina Sof\u00eda de C\u00f3rdoba, Universidad de C\u00f3rdoba, Cordoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero","sequence":"additional","affiliation":[{"name":"Unidad de Enfermedades Infecciosas, Instituto Maimonides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba (IMIBIC), Hospital Universitario Reina Sof\u00eda de C\u00f3rdoba, Universidad de C\u00f3rdoba, Cordoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30579-7"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27259"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.09.010"},{"key":"CIT0004","volume-title":"INCIVEK TM (Telaprevir) film coated tablets US prescribing information","author":"Incorporated VP.","year":"2013"},{"key":"CIT0005","volume-title":"VICTRELIS\u00ae (boceprevir) capsules for oral use. U.S prescribing information","author":"Merck Co Inc","year":"2013"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i4.1421"},{"key":"CIT0007","volume-title":"Sovaldi\u00ae (Sofosbuvir) tablets, for oral use","author":"Gilead Science","year":"2017"},{"key":"CIT0008","volume-title":"OLYSIO \u00ae (Simeprevir) capsules, for oral use","author":"Janssen-Cilag","year":"2017"},{"key":"CIT0009","volume-title":"DAKLINZA TM (Daclatasvir) tablets, for oral use","author":"Bristol-Myers Squibb Company","year":"2017"},{"key":"CIT0010","volume-title":"HARVONI\u00ae (Ledipasvir and Sofosbuvir) tablets, for oral use","author":"Gilead Sciences","year":"2017"},{"key":"CIT0011","volume-title":"VIEKIRA PAK (Ombitasvir, Paritaprevir, and ritonavir tablets; Dasabuvir tablets), co-packaged for oral use","author":"AbbVie Ltd","year":"2017"},{"key":"CIT0012","volume-title":"ZEPATIERTM (Elbasvir and Grazoprevir) tablets, for oral use","author":"Merck Co Inc","year":"2017"},{"key":"CIT0013","volume-title":"Epclusa \u00ae (Sofosbuvir and Velpatasvir) tablets, for oral use","author":"Gilead Sciences Inc","year":"2017"},{"key":"CIT0014","volume-title":"MAVYRET TM (Glecaprevir and Pibrentasvir) tablets, for oral use","author":"Food and Drug Administration","year":"2017"},{"key":"CIT0015","volume-title":"VOSEVI\u00ae (Sofosbuvir, Velpatasvir and Voxilaprevir) tablets, for oral use","author":"Gilead Sciences Inc","year":"2017"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2014.857656"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02666-14"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.12.002"},{"key":"CIT0019","volume-title":"REBETOL\u00ae (ribavirin USP) capsules, for oral use","author":"Merck","year":"2017"},{"issue":"453","key":"CIT0020","first-page":"e457","volume":"147","author":"McGivern DR","year":"2014","journal-title":"Gastroenterology"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24609"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06169-11"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1038\/nature08960"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02788-14"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.775246"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2017.1255725"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2017.1292253"},{"key":"CIT0028","unstructured":"European Medicines Agency. Daklinza (daclatasvir): EU summary of product characteristics; 2016 [cited 2017 Dec 21]. Available from: http:\/\/www.ema.europa.eu\/."},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0632-x"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0362-5"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0247-z"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305771"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014534194"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0261-7"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0420-2"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X13515825"},{"key":"CIT0037","first-page":"17","volume":"19","author":"Glue P","year":"1999","journal-title":"Semin Liver Dis"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/493087"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5455-y"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00836.x"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28446"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw163"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27726"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28473"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.021"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312444"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)01524-5"},{"key":"CIT0049","doi-asserted-by":"crossref","unstructured":"Herzer K, Welzel TM, Spengler U, et al. Real-world experience with daclatasvir plus sofosbuvir \u00b1 ribavirin for post-liver transplant HCV recurrence and severe liver disease. Transpl Int. 2017;30(3):243\u2013255.","DOI":"10.1111\/tri.12910"},{"key":"CIT0050","first-page":"728A","author":"Rockstroh JK","year":"2015","journal-title":"Hepatology"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)01564-6"},{"key":"CIT0052","first-page":"314A","volume":"62","author":"Hezode C","year":"2015","journal-title":"Hepatology"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)01471-9"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)01622-6"},{"key":"CIT0055","volume-title":"8th IAS Conference on HIV Pathogenesis, Treatment and Prevention","author":"Lacombe K","year":"2015"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)01591-9"},{"key":"CIT0057","first-page":"565A","volume":"62","author":"Landis CS","year":"2015","journal-title":"Hepatology"},{"key":"CIT0058","unstructured":"Drug interaction daclatasvir, sofosbuvir and ribavirin. Hep drug interaction; 2017 dec 27. Available from: https:\/\/www.hep-druginteractions.org\/checker"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316145"},{"key":"CIT0062","unstructured":"American Association for the Study of Liver Diseases and Infectious Diseases and Infectious Diseases Society of America. Recommendations for testing, managing, and treating hepatitis C; [cited 2018 Jul 31]. Available from: http:\/\/hcvguidelines.org"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512612"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512614"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.039"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.029"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30496-6"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12648"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24416"},{"key":"CIT0071","unstructured":"World Health Organization. Combating hepatitis B and C to reach elimination by 2030. [cited Sept 21th]. Available at Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/206453\/1\/WHO_HIV_2016.04_eng.pdf"},{"key":"CIT0072","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis action plan for 2017-2020. [cited Sept 21th]. Available from: https:\/\/www.cdc.gov\/hepatitis\/hhs-actionplan.htm"},{"key":"CIT0073","first-page":"167","volume":"19","author":"Cattaneo D","year":"2017","journal-title":"AIDS Rev"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2017.08.003"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2018.1506765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T17:21:44Z","timestamp":1599412904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2018.1506765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":74,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,2]]}},"alternative-id":["10.1080\/17425255.2018.1506765"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2018.1506765","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}